GPCR SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000315066-26-002858
GPCR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. An institutional holder filed an amended Schedule 13G for Structure Therapeutics Inc. (GPCR), indicating a change in passive ownership position.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Structure Therapeutics Inc. (GPCR), indicating a change in passive ownership position. The filing does not disclose a specific ownership percentage in the available text.
Key details
✦ Ask GOAX AI about this filing — what it means for GPCR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GPCR?
Click hereFrequently asked questions
What did GPCR file with the SEC on Nov 5, 2026?
GPCR filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Structure Therapeutics Inc. (GPCR), indicating a change in passive ownership position. The filing does not disclose a specific ownership percentage in the available text.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other GPCR SEC filings
- 8-K · SEC filingSep 8, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 144 · Insider sale plannedJun 25, 2026
- 8-K · SEC filingJun 18, 2026
- 424B5 · Secondary offeringMay 7, 2026
- 8-K · SEC filingMay 7, 2026
- 10-Q · SEC filingMay 7, 2026
- DEF 14A · Board changeApr 23, 2026
- 8-K · SEC filingApr 15, 2026
Get alerts when GPCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days